West Pharmaceutical Services, Inc. (WST)
WST stock forecast: what analysts expect
Wall Street analysts covering West Pharmaceutical Services, Inc. currently rate the stock a Strong Buy on average, with a mean 12-month price target of $407.56 — +10.0% versus the last price of $370.44. Targets reflect analyst opinion, not a guarantee.
WST historical returns
Based on monthly dividend-adjusted prices. See the full breakdown on what if you had invested in WST.
WST annual returns by year
Congress trading in WST
7 members of Congress have disclosed trading WST — 7 purchases and 3 sales worth an estimated $147,000. Most recent disclosure: Jun 17, 2025.
See who in Congress traded WST →Insider activity in WST
WST's own executives and directors have made 0 open-market purchases ($0) and 6 sales ($5.4M) in the last 90 days, per SEC Form 4 filings. Most recent: Sep 15, 2026.
| Sep 15, 2026 | Favorite Annette F | Sr. VP & Chief HR Officer | Sell | $921,260 |
| Sep 14, 2026 | Favorite Annette F | Sr. VP & Chief HR Officer | Sell | $887,500 |
| Sep 11, 2026 | Favorite Annette F | Sr. VP & Chief HR Officer | Sell | $862,500 |
| Sep 8, 2026 | Favorite Annette F | Sr. VP & Chief HR Officer | Sell | $960,062 |
| Sep 8, 2026 | Favorite Annette F | Sr. VP & Chief HR Officer | Sell | $960,403 |
About West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
WST Key Statistics
WST in plain English
- P/E ratio (47.4) — how many dollars you pay for each $1 of WST's yearly profit. That's high, so the market expects strong growth (and you're paying up for it).
- ROE (19.09%) — how efficiently the company turns shareholders' money into profit. This is a middling level.
- Profit margin (16.98%) — of every $1 in sales, this is what's left as profit after all costs.
- Dividend yield (0.24%) — the cash payout you'd earn per year as a % of the share price, on top of any price gains.
WST stock: frequently asked questions
What is West Pharmaceutical Services, Inc.'s stock price today?
West Pharmaceutical Services, Inc. (WST) last traded at $370.44 on the NYSE. Over the past 52 weeks the stock has traded between $223.83 and $386.00.
Is WST stock a buy or a sell?
Wall Street analysts' consensus rating on WST is "Strong Buy", with an average 12-month price target of $407.56 — about +10.0% versus the current price of $370.44. Analyst targets are opinions, not guarantees; always do your own research.
How much would $1,000 invested in WST 10 years ago be worth today?
A $1,000 investment in West Pharmaceutical Services, Inc. made 10 years ago would be worth about $5,157 today (dividends reinvested) — a total return of 416%, or 17.8% per year.
Does WST pay a dividend?
Yes. West Pharmaceutical Services, Inc. currently pays a dividend yielding about 0.24% per year at today's share price.
What is WST's P/E ratio?
WST trades at a trailing price-to-earnings ratio of 47.4, and 37.1 times expected forward earnings. The P/E ratio tells you how many dollars investors pay for each $1 of the company's annual profit.
Do members of Congress trade WST stock?
Yes — 7 members of Congress have disclosed trades in WST under the STOCK Act, totaling 7 purchases and 3 sales worth an estimated $147,000.
What is West Pharmaceutical Services, Inc.'s ticker symbol?
West Pharmaceutical Services, Inc. trades under the ticker symbol WST on the NYSE.
Compare WST with peers
Data last refreshed from public sources. Figures may be delayed. Not investment advice.